Aurinia Pharmaceuticals AUPH Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's operating cash flow?
- Aurinia Pharmaceuticals (AUPH) reported operating cash flow of $32.56M in Q1 2026.
- How has Aurinia Pharmaceuticals's operating cash flow changed year-over-year?
- Aurinia Pharmaceuticals's operating cash flow increased by 2404.6% year-over-year, from $1.3M to $32.56M.
- What is the long-term trend for Aurinia Pharmaceuticals's operating cash flow?
- Over 2 years (2021 to 2025), Aurinia Pharmaceuticals's operating cash flow has grown at a -7.2% compound annual growth rate (CAGR), from -$157.69M to $135.66M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.